Cargando…
Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort
OBJECTIVE: COVID-19 survivors are at risk for long-term health effects, but assessing the sequelae of COVID-19 at large scales is challenging. High-throughput methods to efficiently identify new medical problems arising after acute medical events using the electronic health record (EHR) could improv...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452157/ https://www.ncbi.nlm.nih.gov/pubmed/36005898 http://dx.doi.org/10.1093/jamia/ocac159 |
_version_ | 1784784870174621696 |
---|---|
author | Kerchberger, Vern Eric Peterson, Josh F Wei, Wei-Qi |
author_facet | Kerchberger, Vern Eric Peterson, Josh F Wei, Wei-Qi |
author_sort | Kerchberger, Vern Eric |
collection | PubMed |
description | OBJECTIVE: COVID-19 survivors are at risk for long-term health effects, but assessing the sequelae of COVID-19 at large scales is challenging. High-throughput methods to efficiently identify new medical problems arising after acute medical events using the electronic health record (EHR) could improve surveillance for long-term consequences of acute medical problems like COVID-19. MATERIALS AND METHODS: We augmented an existing high-throughput phenotyping method (PheWAS) to identify new diagnoses occurring after an acute temporal event in the EHR. We then used the temporal-informed phenotypes to assess development of new medical problems among COVID-19 survivors enrolled in an EHR cohort of adults tested for COVID-19 at Vanderbilt University Medical Center. RESULTS: The study cohort included 186 105 adults tested for COVID-19 from March 5, 2020 to November 1, 2021; of which 30 088 (16.2%) tested positive. Median follow-up after testing was 412 days (IQR 274–528). Our temporal-informed phenotyping was able to distinguish phenotype chapters based on chronicity of their constituent diagnoses. PheWAS with temporal-informed phenotypes identified increased risk for 43 diagnoses among COVID-19 survivors during outpatient follow-up, including multiple new respiratory, cardiovascular, neurological, and pregnancy-related conditions. Findings were robust to sensitivity analyses, and several phenotypic associations were supported by changes in outpatient vital signs or laboratory tests from the pretesting to postrecovery period. CONCLUSION: Temporal-informed PheWAS identified new diagnoses affecting multiple organ systems among COVID-19 survivors. These findings can inform future efforts to enable longitudinal health surveillance for survivors of COVID-19 and other acute medical conditions using the EHR. |
format | Online Article Text |
id | pubmed-9452157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94521572022-09-09 Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort Kerchberger, Vern Eric Peterson, Josh F Wei, Wei-Qi J Am Med Inform Assoc Research and Applications OBJECTIVE: COVID-19 survivors are at risk for long-term health effects, but assessing the sequelae of COVID-19 at large scales is challenging. High-throughput methods to efficiently identify new medical problems arising after acute medical events using the electronic health record (EHR) could improve surveillance for long-term consequences of acute medical problems like COVID-19. MATERIALS AND METHODS: We augmented an existing high-throughput phenotyping method (PheWAS) to identify new diagnoses occurring after an acute temporal event in the EHR. We then used the temporal-informed phenotypes to assess development of new medical problems among COVID-19 survivors enrolled in an EHR cohort of adults tested for COVID-19 at Vanderbilt University Medical Center. RESULTS: The study cohort included 186 105 adults tested for COVID-19 from March 5, 2020 to November 1, 2021; of which 30 088 (16.2%) tested positive. Median follow-up after testing was 412 days (IQR 274–528). Our temporal-informed phenotyping was able to distinguish phenotype chapters based on chronicity of their constituent diagnoses. PheWAS with temporal-informed phenotypes identified increased risk for 43 diagnoses among COVID-19 survivors during outpatient follow-up, including multiple new respiratory, cardiovascular, neurological, and pregnancy-related conditions. Findings were robust to sensitivity analyses, and several phenotypic associations were supported by changes in outpatient vital signs or laboratory tests from the pretesting to postrecovery period. CONCLUSION: Temporal-informed PheWAS identified new diagnoses affecting multiple organ systems among COVID-19 survivors. These findings can inform future efforts to enable longitudinal health surveillance for survivors of COVID-19 and other acute medical conditions using the EHR. Oxford University Press 2022-08-25 /pmc/articles/PMC9452157/ /pubmed/36005898 http://dx.doi.org/10.1093/jamia/ocac159 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com https://academic.oup.com/pages/standard-publication-reuse-rightsThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights) |
spellingShingle | Research and Applications Kerchberger, Vern Eric Peterson, Josh F Wei, Wei-Qi Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort |
title | Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort |
title_full | Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort |
title_fullStr | Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort |
title_full_unstemmed | Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort |
title_short | Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort |
title_sort | scanning the medical phenome to identify new diagnoses after recovery from covid-19 in a us cohort |
topic | Research and Applications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452157/ https://www.ncbi.nlm.nih.gov/pubmed/36005898 http://dx.doi.org/10.1093/jamia/ocac159 |
work_keys_str_mv | AT kerchbergerverneric scanningthemedicalphenometoidentifynewdiagnosesafterrecoveryfromcovid19inauscohort AT petersonjoshf scanningthemedicalphenometoidentifynewdiagnosesafterrecoveryfromcovid19inauscohort AT weiweiqi scanningthemedicalphenometoidentifynewdiagnosesafterrecoveryfromcovid19inauscohort |